110
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting

, , , , , , & show all
Pages 1063-1073 | Published online: 23 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hannah R Whittaker, Steven J Kiddle & Jennifer K Quint. (2021) Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV1 Decline in a COPD Population. Pragmatic and Observational Research 12, pages 119-130.
Read now

Articles from other publishers (11)

W. Blake LeMaster, P. Miguel Quibrera, David Couper, Donald P. Tashkin, Eugene R. Bleecker, Claire M. Doerschuk, Victor E. Ortega, Christopher Cooper, MeiLan K. Han, Prescott G. Woodruff, Wanda K. O’Neal, Wayne H. Anderson, Neil E. Alexis, Russell P. Bowler, R. Graham Barr, Robert J. Kaner, Mark T. Dransfield, Robert PaineIIIIII, Victor Kim, Jeffrey L. Curtis, Fernando J. Martinez, Annette T. Hastie & Igor Barjaktarevic. (2023) Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort. Chest 163:3, pages 515-528.
Crossref
Yong Suk Jo, Ji-Yong Moon, Yong Bum Park, Yee Hyung Kim, Soo-Jung Um, Woo Jin Kim, Hyoung Kyu Yoon, Kwang Ha Yoo, Ki-Suck Jung & Chin Kook Rhee. (2022) Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease. BMC Pulmonary Medicine 22:1.
Crossref
Dave Singh, Alvar AgustiFernando J. MartinezAlberto Papi, Ian D. PavordJadwiga A. WedzichaClaus F. Vogelmeier & David M. G. Halpin. (2022) Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. American Journal of Respiratory and Critical Care Medicine 206:1, pages 17-24.
Crossref
Shanya Sivakumaran, Mohammad A. Alsallakh, Ronan A. Lyons, Jennifer K. Quint & Gwyneth A. Davies. (2021) Identifying COPD in routinely collected electronic health records: a systematic scoping review. ERJ Open Research 7:3, pages 00167-2021.
Crossref
Wan C. Tan, Jean Bourbeau, Gilbert Nadeau, Wendy Wang, Neil Barnes, Sarah H. Landis, Miranda Kirby, James C. Hogg & Don D. Sin. (2021) High eosinophil counts predict decline in FEV 1 : results from the CanCOLD study . European Respiratory Journal 57:5, pages 2000838.
Crossref
Benjamin David, Mona Bafadhel, Leo Koenderman & Antony De Soyza. (2021) Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax 76:2, pages 188-195.
Crossref
Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2021) Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?. US Respiratory & Pulmonary Diseases 6:1, pages 31.
Crossref
A. M. Fratta Pasini, C. Stranieri, M. Ferrari, U. Garbin, L. Cazzoletti, C. Mozzini, F. Spelta, D. Peserico & L. Cominacini. (2020) Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study. Respiratory Research 21:1.
Crossref
Marjan Kerkhof, Jaco Voorham, Paul Dorinsky, Claudia Cabrera, Patrick Darken, Janwillem WH Kocks, Mohsen Sadatsafavi, Don D Sin, Victoria Carter & David B Price. (2020) Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax 75:9, pages 744-753.
Crossref
Christian Mang. (2020) Herz und Lunge in der Pneumologie: Pharmakologisch steckt das Organduo in einem Dilemma. Deutsches Ärzteblatt Online.
Crossref
Hannah R. Whittaker, Debbie Jarvis, Mohamed R. Sheikh, Steven J. Kiddle & Jennifer K. Quint. (2019) Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review. Respiratory Research 20:1.
Crossref